Provided by Tiger Fintech (Singapore) Pte. Ltd.

89Bio, Inc.

8.79
+0.24002.81%
Pre-market: 9.100.3100+3.53%08:00 EDT
Volume:1.38M
Turnover:12.09M
Market Cap:1.28B
PE:-2.51
High:9.00
Open:8.45
Low:8.33
Close:8.55
Loading ...

BUZZ-Akero Therapeutics gains after upsized $350 mln equity raise

Reuters
·
29 Jan

89bio Prices $250 Million Offering of Stock, Warrants

MT Newswires Live
·
29 Jan

BRIEF-89Bio Announces Pricing Of $250 Mln Public Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
29 Jan

89Bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
29 Jan

89Bio Inc - Prices Public Offering of 21.7 Mln Shares at $8.75 per Share

THOMSON REUTERS
·
29 Jan

Press Release: 89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Dow Jones
·
29 Jan

89bio Launches $250 Million Securities Offering -- Shares Down After Hours

MT Newswires Live
·
28 Jan

BUZZ-89bio slides on stock offering to fund MASH drug

Reuters
·
28 Jan

89bio announces $250M common stock offering

TIPRANKS
·
28 Jan

89Bio Inc - Commences $250 Million Public Offering

THOMSON REUTERS
·
28 Jan

89Bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
28 Jan

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
28 Jan

Akero's Stock Skyrockets 112% After Game-Changing Liver Drug Data

GuruFocus.com
·
28 Jan

Akero Therapeutics Stock Doubles on Liver Data -- Barrons.com

Dow Jones
·
27 Jan

Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December

Benzinga
·
27 Jan

89bio Price Target Maintained With a $29.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Jan